The high expression of CMTM6 correlates with CD4+/CD8+ lymphocyte infiltration in CRC, demonstrating that CMTM6 has an important role in the immune microenvironment of CRC and can be a prognostic factor in CRC (Peng et al., 2021). This evidence concerns the gene CD4 and colorectal carcinoma.